PUBLICACIÓN
Discovery and mechanism of action studies of 4,6-diphenylpyrimidine-2-carbohydrazides as utrophin modulators for the treatment of Duchenne muscular dystrophy
Vuorinen A. et al.
2021 EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
Drug Discovery (Q1), Medicine (miscellaneous) (Q1), Organic Chemistry (Q1), Pharmacology (Q1)
JCR: 7.088
SJR: 1.054
CITAS
11
DOI
10.1016/j.ejmech.2021.113431
EID
2-s2.0-85108022709
ISSN
0223-5234
EISSN
1768-3254
BIBTEX
@article{Vuorinen_2021, doi = {10.1016/j.ejmech.2021.113431}, url = {https://doi.org/10.1016%2Fj.ejmech.2021.113431}, year = 2021, month = {aug}, publisher = {Elsevier {BV}}, volume = {220}, pages = {113431}, author = {Aini Vuorinen and Isabel V.L. Wilkinson and Maria Chatzopoulou and Ben Edwards and Sarah E. Squire and Rebecca J. Fairclough and Noelia Araujo Bazan and Josh A. Milner and Daniel Conole and James R. Donald and Nandini Shah and Nicky J. Willis and R. Fernando Mart{\'{\i}}nez and Francis X. Wilson and Graham M. Wynne and Stephen G. Davies and Kay E. Davies and Angela J. Russell}, title = {Discovery and mechanism of action studies of 4,6-diphenylpyrimidine-2-carbohydrazides as utrophin modulators for the treatment of Duchenne muscular dystrophy}, journal = {European Journal of Medicinal Chemistry}}
AUTORES DE LA UEX